Effects of tetrahydropapaveroline and salsolinol on cerebral monoamine metabolism and their interactions with psychopharmacological drugs.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D004347:Drug Interactions; D005260:Female; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D010208:Papaverine / Q000031:analogs & derivatives*; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D012490:Salsoline Alkaloids / Q000494:pharmacology*; D013765:Tetrahydropapaveroline / Q000494:pharmacology*
D001679:Biogenic Amines; D007546:Isoquinolines; D011619:Psychotropic Drugs; D012490:Salsoline Alkaloids; D013765:Tetrahydropapaveroline; D010208:Papaverine; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase